Bristol-Myers Squibb Company Ce
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Bristol-Myers Squibb Company Ce's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 2% to $45,006,000,000. The net income raised on $8,025,000,000 and profit margin reached 18%. Total operating expenses were $34,313,000,000.

Profit Margin

Bristol-Myers Squibb Company Ce (NYSE:CELG-RI): Profit margin
2014 15.87B 2.00B 12.62%
2015 16.56B 1.62B 9.81%
2016 19.42B 4.45B 22.94%
2017 20.77B 1.00B 4.85%
2018 22.56B 4.95B 21.95%
2019 26.14B 3.43B 13.15%
2020 42.51B -8.99B -21.16%
2021 46.38B 6.99B 15.08%
2022 46.15B 6.32B 13.71%
2023 45.00B 8.02B 17.83%

CELG-RI Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
45.00B46.15B46.38B42.51B26.14B22.56B20.77B19.42B16.56B15.87B
Cost of revenue
10.69B10.13B9.94B11.77B8.07B6.54B6.06B4.94B3.90B3.93B
Gross profit
34.31B36.02B36.44B30.74B18.06B16.01B14.71B14.48B12.65B11.94B
Operating exp.
Research and development
9.29B9.50B10.19B11.14B6.14B6.34B6.41B4.94B5.92B4.53B
Selling and marketing
1.4B7.81B7.69B7.66B4.87B4.55B4.68B4.91B4.84B4.82B
Total operating expenses
34.31B26.91B27.90B28.56B12.15B10.89B11.26B9.94B10.92B10.23B
Operating income
17.24B10.32B10.15B5.12B5.46B5.11B3.45B4.53B1.73B1.71B
Other income (expenses), net
-8.80B-2.61B-2.06B-7.41B-489M1.07B-108M1.54B347M667M
Income before tax
8.44B7.71B8.09B-6.87B4.97B6.01B5.13B5.91B2.16B2.38B
Income tax expense
400M1.36B1.08B2.12B1.51B1.03B4.15B1.40B477M352M
Net income
8.02B6.32B6.99B-8.99B3.43B4.95B1.00B4.45B1.62B2.00B
Earnings per share
Basic EPS
3.882.973.15-3.982.023.030.612.670.971.21
Diluted EPS
3.862.953.12-3.982.013.030.612.650.971.2
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source